MUMBAI, India, July 9, 2019 /PRNewswire/ -- India-based Accutest Biologics Private Limited (ABPL), a leading CRO for high-quality Biochemical characterization and Bioanalytical services supporting preclinical and clinical development of Biologics and Biosimilars, has received the prestigious OECD-Good Laboratory Practice (GLP) certificati

STOCKHOLM, July 9, 2019 /PRNewswire/ -- Clinical study data on switching haemophilia A and B patients from on-demand treatment to extended half-life (EHL) prophylaxis showed a positive impact on clinical outcomes, with improvements in quality of life (QoL) and reduced annual bleeding rates (ABR). The results of these joint studies by

RIDGEFIELD, Conn., July 8, 2019 /PRNewswire/ -- Boehringer Ingelheim today announced results from two pediatric studies of Pradaxa®, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia.

RANCHO CUCAMONGA, Calif., July 8, 2019 /PRNewswire/ -- The Governing Board of Inland Empire Health Plan (IEHP) has announced that IEHP Chief Operating Officer Jarrod B. McNaughton will succeed Dr. Bradley P. Gilbert as Chief Executive Officer, effective July 20, 2019.

AUSTIN, Texas, July 8, 2019 /PRNewswire/ -- Direct Biologics, LLC announces the launch of ExoFloTM Exosomes. The mission of Direct Biologics is to deliver dis

AUSTIN, Texas, July 8, 2019 /PRNewswire/ -- Direct Biologics, LLC announces the launch of ExoFloTM Exosomes. The mission of Direct Biologics is to deliver dis

SAN DIEGO, July 8, 2019 /PRNewswire/ -- More than 200,000 in-hospital cardiac arrests occur annually in the United States, with survival rates at less than 26%. Patients who suffer a cardiac arrest must receive the highest quality CPR possible, which is known to be the cornerstone for survival; however, certain

LYNDHURST, N.J., July 8, 2019 /PRNewswire/ -- CCA Industries, Inc. (OTC: "CAWW") announced today its results for the second quarter and six months ended May 31, 2019, which can be found in the table below.

JAMES E. WAGNER CULTIVATION CORPORATION HAS BEEN APPROVED FOR THE SALE OF CANNABIS OILS TORONTO, July 8, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV: RIV) (OTC: CNPOF) is pleased to share that its portfolio company, James E. Wagner Cultivation Corporation ("JWC") (TSXV: JWCA) (OTCQX: J

HURLEYVILLE, N.Y., July 8, 2019 /PRNewswire/ -- On Thursday, July 4, 2019, The Center for Discovery (The Center) and its students and resident